Roche Holding AG (RO)

Currency in CHF
355.20
-1.20(-0.34%)
Delayed Data·
Earnings results expected in 3 days
RO is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
352.00355.40
52 wk Range
244.00357.60
Key Statistics
Bid/Ask
354.80 / 355.20
Prev. Close
356.4
Open
353.6
Day's Range
352-355.4
52 wk Range
244-357.6
Volume
2.31K
Average Volume (3m)
25.84K
1-Year Change
21.2287%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
RO Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
360.00
Upside
+1.35%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple

Roche Holding AG News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Buy
Moving Averages
Strong Buy

Roche Holding Company Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagnostic instruments; and digital health solutions. The company was founded in 1896 and is based in Basel, Switzerland.

Employees
103249

Compare RO to Peers and Sector

Metrics to compare
RO
Peers
Sector
Relationship
P/E Ratio
31.5x35.8x−0.6x
PEG Ratio
−2.80−0.170.00
Price/Book
10.4x6.2x2.6x
Price / LTM Sales
4.7x5.4x3.4x
Upside (Analyst Target)
1.0%14.7%41.8%
Fair Value Upside
Unlock0.3%4.8%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 360.00
(+1.35% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 11.74%
Dividend Yield
2.72%
Industry Median 1.96%
Annualised payout
9.70
Paid annually
5-Years Growth
+1.51%
Growth Streak

Earnings

Latest Release
Oct 23, 2025
EPS / Forecast
-- / --
Revenue / Forecast
14.92B / 15.27B
EPS Revisions
Last 90 days

People Also Watch

231.10
SCHN
-0.32%
115.46
NOVN
-0.16%
79.72
SASY
+0.52%
62.26
NVO
+0.05%
151.45
CFR
-2.01%

FAQ

What Is the Roche Holding (RO) Share Price Today?

The live Roche Holding share price today is 355.20

What Stock Exchange Does Roche Holding (RO) Trade On?

Roche Holding is listed and trades on the Switzerland Stock Exchange.

What Is the Ticker (Stock Symbol) for Roche Holding?

The stock symbol (also called a 'ticker') for Roche Holding is "RO."

Does Roche Holding Pay Dividends? What’s The Current RO Dividend Yield?

Yes, RO Pays Dividends to its Shareholders. The current Roche Holding dividend yield is 2.72%.

What Is the Current Roche Holding Market Cap?

As of today, Roche Holding market capitalisation is 302.03B.

What Is Roche Holding's (RO) Earnings Per Share (TTM)?

The Roche Holding EPS is currently 11.74 (Trailing Twelve Months).

When Is the Next Roche Holding Earnings Date?

Roche Holding's next earnings report will be released on 29 Jan 2026.

Is RO a Buy or Sell From a Technical Analyst Perspective?

Based on today's Roche Holding moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Roche Holding Stock Split?

Roche Holding has split 1 times. (See the RO stock split history page for full effective split date and price information.)

How Many Employees Does Roche Holding Have?

Roche Holding has 103249 employees.

What is the current trading status of Roche Holding (RO)?

As of 26 Jan 2026, Roche Holding (RO) is trading at a price of 355.20, with a previous close of 356.40. The stock has fluctuated within a day range of 352.00 to 355.40, while its 52-week range spans from 244.00 to 357.60.

What Is Roche Holding (RO) Price Target According to Analysts?

The average 12-month price target for Roche Holding is CHF360.00, with a high estimate of CHF360 and a low estimate of CHF360. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +1.35% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.